BioCryst names David Jenkins chief scientific officer - BCRX News | RalliesBioCryst names David Jenkins chief scientific officer
B
BCRX• BioCryst appoints Jenkins as chief scientific officer
- BioCryst appointed David W. Jenkins as chief scientific officer, effective immediately, in a newly created role.
- Jenkins reports to Chief Research and Development Officer Sandeep Menon.
- He will build and lead a research team focused on external innovation partnerships to accelerate rare disease therapy development.
- Jenkins previously served as senior vice president, head of research and external innovation at Ipsen.
- Earlier roles included scientific leadership posts at TESARO, MedImmune, Novartis, AstraZeneca.
•
